Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine-pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal

Parasitology Research

Volumn 109, Issue 1, 2011, Pages 133-138

  Faye, Babacar ^a   Ndiaye, Magatte ^a   Ndiaye, Jean Louis ^a   Annie, Abiola ^a   Tine, Roger Clement ^a   Lo, Aminata Collé ^a   Ndiaye, Mohamed ^a   Sow, Doudou ^a   De Sousa, Alexandra ^b   Gaye, Oumar ^a  

^a UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

^b Health Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE PLUS SULFADOXINE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIHYDROFOLATE REDUCTASE GENE; DIHYDROPTEROATE SYNTHASE GENE; GENE; GENE MUTATION; GENETIC MARKER; HEALTH SURVEY; HUMAN; INFANT; MALARIA; MALARIA CONTROL; MUTATIONAL ANALYSIS; NONHUMAN; PARASITE IDENTIFICATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PUBLIC HOSPITAL; SENEGAL;

ANTIMALARIALS; BLOOD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIHYDROPTEROATE SYNTHASE; DNA, PROTOZOAN; DRUG COMBINATIONS; DRUG RESISTANCE; GENETIC MARKERS; HUMANS; IMMUNIZATION; INFANT; INFANT, NEWBORN; MALARIA, FALCIPARUM; MUTATION, MISSENSE; PILOT PROJECTS; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREVALENCE; PYRIMETHAMINE; SENEGAL; SPECIMEN HANDLING; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

PLASMODIUM FALCIPARUM;

EID: 79959378349     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-010-2236-9     Document Type: Article

References (22)

1. JJ Aponte D Schellenberg A Egan A Breckenridge I Carneiro J Critchley I Danquah A Dodoo R Kobbe B Lell J May Z Premji S Sanz E Sevene R Soulaymani-Becheikh P Winstanley S Adjei S Anemana D Chandramohan S Issifou F Mockenhaupt S Owusu-Agyei B Greenwood MP Grobusch PG Kremsner E Macete H Mshinda RD Newman L Slutsker M Tanner P Alonso C Menendez 2009 Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials Lancet 374 9700 1533 1542
2. D Chandramohan S Owusu-Agyei I Carneiro T Awine K Amponsa-Achiano N Mensah S Jaffar R Baiden A Hodgson F Binka B Greenwood 2005 Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana BMJ 331 7519 727 733 (Pubitemid 41414939)
3. B Cissé C Sokhna D Boulanger J Milet H Bâ el K Richardson R Hallett C Sutherland K Simondon F Simondon N Alexander O Gaye G Targett J Lines B Greenwood JF Trape 2006 Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial Lancet 367 9511 659 667 (Pubitemid 43289156)
4. A Dicko I Sagara AA Djimdé SO Touré M Traore S Dama AI Diallo A Barry M Dicko OM Coulibaly C Rogier A de Sousa OK Doumbo 2010 Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali Malar J 9 9
5. OK Doumbo K Kayentao A Djimde JF Cortese Y Diourte A Konaré JG Kublin CV Plowe 2000 Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis J Infect Dis 182 3 993 996
6. EC Eboumbou Moukoko H Bogreau S Briolant B Pradines C Rogier 2009 Molecular markers of Plasmodium falciparum drug resistance Med Trop 69 606 612
7. S Enosse P Magnussen F Abacassamo X Gómez-Olivé AM Rønn R Thompson M Alifrangis 2008 Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine- pyrimethamine as first line treatment in 2002, in southern Mozambique Malar J 7 115
8. JF Etard V Delaunay JY Le Hesran JL Ndiaye JP Diallo 2004 Childhood mortality and probable causes of death using verbal autopsy in Niakhar, Senegal, 1989-2000 Int J Epidemiol 33 6 1286 1292 (Pubitemid 40124930)
9. MP Grobusch B Lell NG Schwarz J Gabor J Dornemann M Potschke S Oyakhirome GC Kiessling M Necek MU Langin P Klein Klouwenberg A Klopfer B Naumann H Altun ST Agnandji J Goesch M Decker CL Salazar C Supan DU Kombila L Borchert KB Koster P Pongratz AA Adegnika I Glasenapp S Issifou PG Kremsner 2007 Intermittent preventive treatment against malaria in infants in Gabon-a randomized, double-blind, placebo-controlled trial J Infect Dis 196 11 1595 1602 (Pubitemid 351411956)
10. RH Henderson T Sundundarset 1982 Cluster sampling to assess immunization coverage. A review experience with a simplified method Bull World Health Org 60 253 260 (Pubitemid 13255613)
11. JG Kublin FK Dzinjalamala DD Kamwendo EM Malkin JF Cortese LM Martino RA Mukadam SJ Rogerson AG Lescano ME Molyneux PA Winstanley P Chimpeni TE Taylor CV Plowe 2002 Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria J Infect Dis 185 3 380 388 (Pubitemid 34107252)
12. E Macete P Aide JJ Aponte S Sanz I Mandomando M Espasa B Sigauque C Dobaño S Mabunda M DgeDge P Alonso C Menendez 2006 Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial J Infect Dis 194 3 276 285 (Pubitemid 44116968)
13. A Mayor E Serra-Casas S Sanz JJ Aponte E Macete I Mandomando L Puyol P Berzosa C Dobaño P Aide J Sacarlal A Benito P Alonso C Menéndez 2008 Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants J Infect Dis 197 12 1737 1742 (Pubitemid 351919639)
14. Ministère de la Santé et de la Prévention Médicale. (2006). Centre de Recherche pour le Développement Humain Dakar, Sénégal Enquête Démographique et de Santé Sénégal 2005 (EDS IV)
15. FP Mockenhaupt G Bedu-Addo TA Eggelte L Hommerich V Holmberg C von Oertzen U Bienzle 2008 Rapid increase in the prevalence of sulfadoxine- pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana J Infect Dis 198 10 1545 1549
16. D Ndiaye JP Daily O Sarr O Ndir O Gaye S Mboup DF Wirth 2005 Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal Trop Med Int Health 10 11 1176 1179 (Pubitemid 41641196)
17. D Ndiaye JP Daily O Sarr O Ndir O Gaye S Mboup C Roper DF Wirth 2006 Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal Acta Trop 99 1 106 111 (Pubitemid 44402244)
18. WP O'Meara DL Smith FE McKenzie 2006 Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria PLoS Med 3 5 e141
19. S Picot P Olliaro F de Monbrison AL Bienvenu RN Price P Ringwald 2009 A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria Malar J 8 89
20. CV Plowe A Djimde M Bouare O Doumbo TE Wellems 1995 Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa Am J Trop Med Hyg 52 6 565 568
21. D Schellenberg C Menendez E Kahigwa J Aponte J Vidal M Tanner H Mshinda P Alonso 2001 Intermittent treatment for malaria and anaemia control at time of routine vaccinations in infants: a randomised, placebo-controlled trial Lancet 357 1471 1477
22. H Sendagire D Kyabayinze G Swedberg F Kironde 2005 Plasmodium falciparum: higher incidence of molecular resistance markers for sulphadoxine than for pyrimethamine in Kasangati, Uganda Trop Med Int Health 10 6 537 543 (Pubitemid 40806659)